Gilead Up Nearly 6%, Best Performer in the S&P 500 So Far Today -- Data Talk
04 February 2020 - 7:36AM
Dow Jones News
Gilead Sciences, Inc. (GILD) is currently at $66.74, up $3.54 or
5.6%
-- Would be highest close since Dec. 23, 2019, when it closed at
$66.75
-- On pace for largest percent increase since Aug. 30, 2017,
when it rose 7.25%
-- On Friday, The Wall Street Journal reported that Chinese
officials had reached an agreement with Gilead to test remdesivir
in patients with coronavirus. The same day, the New England Journal
of Medicine published a case report on a man sickened with the
coronavirus in Washington state who was given remdesivir, and whose
condition began to improve the following day
-- Snaps a three day losing streak
-- Down 45.39% from its all-time closing high of $122.21 on June
23, 2015
-- Traded as high as $68.68; highest intraday level since July
5, 2019, when it hit $69.34
-- Up 8.67% at today's intraday high; largest intraday percent
increase since Nov. 12, 2012, when it rose as much as 14.35%
-- Best performer in the S&P 500 today
-- Third best performer in the Nasdaq 100 today
All data as of 2:58:18 PM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 03, 2020 15:21 ET (20:21 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2024 to May 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2023 to May 2024